Exploration of SAR features by modifications of thiazoleacetic acids as CRTH2 antagonists
Research output: Contribution to journal › Journal article › Research › peer-review
Standard
Exploration of SAR features by modifications of thiazoleacetic acids as CRTH2 antagonists. / Grimstrup, Marie; Receveur, Jean Marie; Rist, Øystein; Frimurer, Thomas M.; Nielsen, Peter Aadal; Mathiesen, Jesper M.; Högberg, Thomas.
In: Bioorganic and Medicinal Chemistry Letters, Vol. 20, No. 5, 01.03.2010, p. 1638-1641.Research output: Contribution to journal › Journal article › Research › peer-review
Harvard
APA
Vancouver
Author
Bibtex
}
RIS
TY - JOUR
T1 - Exploration of SAR features by modifications of thiazoleacetic acids as CRTH2 antagonists
AU - Grimstrup, Marie
AU - Receveur, Jean Marie
AU - Rist, Øystein
AU - Frimurer, Thomas M.
AU - Nielsen, Peter Aadal
AU - Mathiesen, Jesper M.
AU - Högberg, Thomas
PY - 2010/3/1
Y1 - 2010/3/1
N2 - The SAR features have been further explored for (2-benzhydryl-4-phenyl-thiazol-5-yl)acetic acids as CRTH2 (chemoattractant receptor-homologous molecule expressed on Th2 cells) antagonists. The introduction of a nitrogen or a methyl substituent in the benzhydrylic position offer two alternative drugable scaffolds attractive for unsymmetrically substituted derivatives. An imidazole analogue lacks activity due to formation of a favored coplanar intramolecular hydrogen bond. The pyrimidine derivative 18 represents a potent and selective compound that will be subject to continued investigations.
AB - The SAR features have been further explored for (2-benzhydryl-4-phenyl-thiazol-5-yl)acetic acids as CRTH2 (chemoattractant receptor-homologous molecule expressed on Th2 cells) antagonists. The introduction of a nitrogen or a methyl substituent in the benzhydrylic position offer two alternative drugable scaffolds attractive for unsymmetrically substituted derivatives. An imidazole analogue lacks activity due to formation of a favored coplanar intramolecular hydrogen bond. The pyrimidine derivative 18 represents a potent and selective compound that will be subject to continued investigations.
KW - Chemoattractant receptor-homologous molecule expressed on Th2 cells
KW - CRTH2 antagonists
KW - Molecular modelling
KW - PGD2
KW - Scaffold hopping
KW - Structure-activity relationships
UR - http://www.scopus.com/inward/record.url?scp=76649106066&partnerID=8YFLogxK
U2 - 10.1016/j.bmcl.2010.01.092
DO - 10.1016/j.bmcl.2010.01.092
M3 - Journal article
C2 - 20137942
AN - SCOPUS:76649106066
VL - 20
SP - 1638
EP - 1641
JO - Bioorganic & Medicinal Chemistry Letters
JF - Bioorganic & Medicinal Chemistry Letters
SN - 0960-894X
IS - 5
ER -
ID: 221756761